Copyright
©The Author(s) 2025.
World J Clin Pediatr. Mar 9, 2025; 14(1): 100386
Published online Mar 9, 2025. doi: 10.5409/wjcp.v14.i1.100386
Published online Mar 9, 2025. doi: 10.5409/wjcp.v14.i1.100386
Variables | Total, n = 595 (100) | IgE-mediated, n = 135 (22.7) | Non-IgE-mediated, n = 460 (77.3) | P value |
Nationality | 1.000a | |||
Bahraini | 558 (93.8) | 127 (94.1) | 431 (93.7) | |
Non-Bahraini | 37 (6.2) | 8 (5.9) | 29 (6.3) | |
Governorate | ||||
Northern | 66 (48.9) | 228 (49.6) | 294 (49.4) | 0.536b |
Capital | 39 (28.9) | 115 (25.0) | 154 (25.9) | |
Muharraq | 18 (13.3) | 57 (12.4) | 75 (12.6) | |
Southern | 12 (8.9) | 60 (13.0) | 72 (12.1) | |
Sex | 0.030a | |||
Male | 329 (55.3) | 86 (63.7) | 243 (52.8) | |
Female | 266 (44.7) | 49 (36.3) | 217 (47.2) | |
Gestational age (n = 539) | 0.418a | |||
Full term | 445 (82.6) | 104 (85.2) | 341 (81.8) | |
Preterm | 94 (17.4) | 18 (14.8) | 76 (18.2) | |
Delivery (n = 530) | 0.914a | |||
Normal delivery | 333 (62.8) | 75 (63.6) | 258 (62.6) | |
Cesarean section | 197 (37.2) | 43 (36.4) | 154 (37.4) | |
Birth weight (kg) (n = 512) | 2.9 (2.5-3.3) | 2.9 (2.5-3.3) | 2.9 (2.5-3.3) | 0.626c |
Birth weight group (kg) (n = 512) | 0.701a | |||
< 2.5 | 111 (21.7) | 27 (23.3) | 84 (21.2) | |
≥ 2.5 | 401 (78.3) | 89 (76.7) | 312 (78.8) | |
Age at presentation (months) | 3 (2-5) | 4 (2-7) | 3 (2-5) | 0.009c |
Age group (months) (n = 589) | 0.031b | |||
< 6 | 464 (78.0) | 93 (68.9) | 371 (80.7) | |
6-12 | 102 (17.1) | 34 (25.2) | 68 (14.8) | |
13-24 | 25 (4.2) | 7 (5.2) | 18 (3.9) | |
> 24 | 4 (0.7) | 1 (0.7) | 3 (0.7) | |
Associated diseases1 | 226 (38.0) | 70 (51.9) | 156 (33.9) | < 0.001a |
Number of outpatient visits | 4 (2-7) | 5 (3-7) | 4 (2-7) | 0.123c |
Follow-up duration (months) | 11.8 (5.5-18.2) | 13.5 (8.3-21.8) | 11.3 (5.0-16.9) | < 0.001c |
Age at last follow-up (years) | 1.3 (0.8-1.9) | 1.6 (1.1-2.2) | 1.2 (0.8-1.8) | < 0.001c |
Age group at last follow-up (years) | < 0.001b | |||
< 1 | 25 (18.5) | 171 (37.2) | 196 (32.9) | |
1-3 | 92 (68.1) | 254 (55.2) | 346 (58.2) | |
4-6 | 16 (11.9) | 27 (5.9) | 43 (7.2) | |
> 6 | 2 (1.5) | 8 (1.7) | 10 (1.7) | |
FH of allergies2 | 222 (37.3) | 59 (43.7) | 163 (35.4) | 0.086a |
FH of food allergy | 159 (26.7) | 41 (69.5) | 118 (72.4) | 0.737a |
FH of cow’s milk allergy | 130 (21.8) | 29 (49.2) | 101 (62.0) | 0.092a |
FH of other allergies3 | 89 (15.0) | 25 (42.4) | 64 (39.3) | 0.757a |
- Citation: Isa HM, Abdulnabi MJ, Naser NS, Lahmda FN, AlAnsari NM, Isa ZH, Mohamed AM. Clinical, laboratory, and therapeutic differences between immunoglobulin E-mediated and non-immunoglobulin E-mediated cow’s milk protein allergy in children. World J Clin Pediatr 2025; 14(1): 100386
- URL: https://www.wjgnet.com/2219-2808/full/v14/i1/100386.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i1.100386